Hypoadiponectinemia: A Link between Visceral Obesity and Metabolic Syndrome
Table 2
International Diabetes Federation (IDF) metabolic syndrome worldwide definition (IDF, 2006).
Central obesity
Waist circumference—ethnicity specific plus any two of the following:
Raised triglycerides
≥1.7 mmol/L (150 mg/dl) or specific treatment
Reduced HDL-C
<1.03 mmol/L (40 mg/dl in males) <1.29 mmol/L (50 mg/dl) in females or specific treatment
Raised blood pressure
Systolic ≥130 mmHg or Diastolic ≥85 mmHg or treatment of previously diagnosed hypertension
Raised fasting plasma glucose
Fasting plasma glucose ≥5.6 mmol/L (100 mg/dl) or previously diagnosed Type 2 diabetes. If >5.6 mmol/L or 100 mg/dl, oral glucose tolerance test is strongly recommended but is not necessary to define presence of the syndrome.
This is the first classification indicating central obesity as an obligatory component of MetS. HDL-C: High-density lipoprotein-cholesterol.